These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 16988552

  • 1. Fibrinolytic response to exercise in women using third-generation oral contraceptives.
    Weiss C, Walter B, Dorsch MF, Bärtsch P.
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):563-8. PubMed ID: 16988552
    [Abstract] [Full Text] [Related]

  • 2. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 3. A randomised, controlled study of the effects of aerobic exercise and dietary fish on coagulation and fibrinolytic factors in type 2 diabetics.
    Dunstan DW, Mori TA, Puddey IB, Beilin LJ, Burke V, Morton AR, Stanton KG.
    Thromb Haemost; 1999 Mar; 81(3):367-72. PubMed ID: 10102462
    [Abstract] [Full Text] [Related]

  • 4. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A, Rosc D, Bronisz M, Szymanski W, Junik R.
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [Abstract] [Full Text] [Related]

  • 5. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 6. Elevated plasma fibrinogen and increased fibrin turnover among healthy women who both smoke and use low-dose oral contraceptives--a preliminary report.
    Scarabin PY, Vissac AM, Kirzin JM, Bourgeat P, Amiral J, Agher R, Guize L.
    Thromb Haemost; 1999 Sep; 82(3):1112-6. PubMed ID: 10494773
    [Abstract] [Full Text] [Related]

  • 7. Human gender differences in fibrinolytic responses to exercise training and their determinants.
    Kulaputana O, Macko RF, Ghiu I, Phares DA, Goldberg AP, Hagberg JM.
    Exp Physiol; 2005 Nov; 90(6):881-7. PubMed ID: 16118237
    [Abstract] [Full Text] [Related]

  • 8. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
    Hoetzer GL, Stauffer BL, Greiner JJ, Casas Y, Smith DT, DeSouza CA.
    Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E90-5. PubMed ID: 12388132
    [Abstract] [Full Text] [Related]

  • 9. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR, Skouby SO, Jespersen J.
    Int J Fertil Menopausal Stud; 1995 Jan; 40 Suppl 2():105-11. PubMed ID: 8574252
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2008 Jan; 121(6):787-91. PubMed ID: 17869326
    [Abstract] [Full Text] [Related]

  • 11. Effects of supplementation with alpha-lipoic acid on exercise-induced activation of coagulation.
    Weiss C, Bierhaus A, Nawroth PP, Bärtsch P.
    Metabolism; 2005 Jun; 54(6):815-20. PubMed ID: 15931620
    [Abstract] [Full Text] [Related]

  • 12. The kinetics of plasmin inhibition by aprotinin in vivo.
    Kang HM, Kalnoski MH, Frederick M, Chandler WL.
    Thromb Res; 2005 Jun; 115(4):327-40. PubMed ID: 15668193
    [Abstract] [Full Text] [Related]

  • 13. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 14. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia.
    Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M.
    Thromb Haemost; 1997 May; 77(5):970-4. PubMed ID: 9184412
    [Abstract] [Full Text] [Related]

  • 15. Effects of oral contraceptives on fibrinolytic response to exercise.
    De Paz JA, Villa JG, Vilades E, Martin-Nuño MA, Lasierra J, Gonzalez-Gallego J.
    Med Sci Sports Exerc; 1995 Jul; 27(7):961-6. PubMed ID: 7564982
    [Abstract] [Full Text] [Related]

  • 16. [Oral contraceptive agents and the fibrinolytic system].
    Nalbanski B, Kamenov V.
    Akush Ginekol (Sofiia); 1989 Jul; 28(6):51-5. PubMed ID: 2483796
    [Abstract] [Full Text] [Related]

  • 17. Fibrinolytic response in women on low-dose oral contraceptive.
    Ishak R, Ahmad R, Gudum HR, Hassan K, Ang ES.
    Malays J Reprod Health; 1992 Jun; 10(1):7-11. PubMed ID: 12345026
    [Abstract] [Full Text] [Related]

  • 18. The diurnal increase in euglobulin fibrinolytic activity in women using oral contraceptives and in normal women, and the generation of intrinsic fibrinolytic activity.
    Jespersen J.
    Thromb Haemost; 1986 Oct 21; 56(2):183-8. PubMed ID: 3101221
    [Abstract] [Full Text] [Related]

  • 19. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT, Acar K, Sucak A, Kirazli S, Haznedar R.
    Blood Coagul Fibrinolysis; 2006 Jul 21; 17(5):347-52. PubMed ID: 16788310
    [Abstract] [Full Text] [Related]

  • 20. Regular alcohol intake and fibrinolysis.
    van Golde PM, Hart HCh, Kraaijenhagen RJ, Bouma BN, van de Wiel A.
    Neth J Med; 2002 Aug 21; 60(7):285-8. PubMed ID: 12430575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.